Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacogenomics Moves Into Spotlight With Completion Of Genome Project

Executive Summary

Industry is ready to "embrace" pharmacogenomic-based drug development as long as commercial and regulatory applications are based on a full understanding of the technology, AstraZeneca VP-Clinical Development Glenn Gormley, MD/PhD, said during FDA's risk management public workshop April 9

You may also be interested in...



Drug Development Too Risky Without Pharmacogenomics, McClellan Says

The future of drug development is too risky without the use of pharmacogenomics-based therapies, FDA Commissioner McClellan told a Drug Information Association workshop Nov. 13

Drug Development Too Risky Without Pharmacogenomics, McClellan Says

The future of drug development is too risky without the use of pharmacogenomics-based therapies, FDA Commissioner McClellan told a Drug Information Association workshop Nov. 13

Parexel Consulting Business Slowed By Fewer FDA GMP Enforcement Actions

Parexel's manufacturing compliance consulting business has slowed because of fewer FDA good manufacturing practice enforcement actions

Related Content

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel